FDA Grants Expanded Approval to Wilate as the First VWF Concentrate for Prophylaxis in All Types of VWD

Paramus, NJ 07/12/2023 Octapharma USA announced the expansion of the U.S. Food and Drug Administration (FDA) approval for wilate®, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news